Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$18,764,573
+$1,470,199 QoQ
Shares Held
73,885
+4.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#771
of 4,676 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tema ETFs LLC holds $109,379,794 across 9 Drug Manufacturers - General names. JNJ ranks #2 (17.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,006 | $29,992,949 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
73,885 | $18,764,573 | |
| 3 | MRK |
Merck & Co., Inc.
|
122,900 | $15,792,650 | |
| 4 | ABBV |
AbbVie Inc.
|
61,759 | $15,541,034 | |
| 5 | AMGN |
Amgen Inc
|
26,231 | $9,498,769 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
164,530 | $9,480,218 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
57,158 | $7,221,341 | |
| 8 | PFE |
Pfizer Inc
|
103,378 | $2,489,342 |
All Filings in JNJ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,764,573 | 73,885 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $17,294,374 | 70,751 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $14,254,922 | 68,881 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $7,574,963 | 40,853 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||